[1]
Jalil, J.E.; Doering, C.W.; Janicki, J.S.; Pick, R.; Shroff, S.G.; Weber, K.T. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ. Res., 1989, 64, 1041-1050.
[2]
Verdecchia, P.; Schillaci, G.; Borgioni, C.; Ciucci, A.; Gattobigio, R.; Zampi, I.; Reboldi, G.; Porcellati, C. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation, 1998, 273, 2161-2168.
[3]
Sia, Y.T.; Lapointe, N.; Parker, T.G.; Tsoporis, J.N.; Deschepper, C.F.; Calderone, A.; Pourdjabbar, A.; Jasmin, J.F.; Sarrazin, J.F.; Liu, P.; Adam, A.; Butany, J.; Rouleau, J.L. Beneficial effects of long-term use of the antioxidant probucol in heart failure in rat. Circulation, 2002, 105, 2549-2555.
[4]
Gerber, I.L.; Stewart, R.A.; Hammett, C.J.; Legget, M.E.; Oxenham, H.; West, T.M.; French, J.K.; White, H.D. Effect of aortic valve replacement on C-reactive protein in non-rheumatic aortic stenosis. Am. J. Cardiol., 2003, 92, 1129-1132.
[5]
Tsutamoto, T.; Wada, A.; Maeda, K.; Hisanaga, T.; Maeda, Y.; Fukai, D.; Ohnishi, M.; Sugimoto, Y.; Kinoshita, M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997, 96, 509-516.
[6]
Berger, R.; Huelsmann, M.; Strecker, K.; Bojic, A.; Moser, P.; Stanek, B.; Brigitte Stanek, B.; Pacher, R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation, 2002, 105, 2392-2397.
[7]
Jalil, J.E.; Doering, C.W.; Janicki, J.S.; Pick, R.; Clark, W.A.; Abrahams, C.; Weber, K.T. Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle. J. Mol. Cell. Cardiol., 1988, 20, 1179-1187.
[8]
Khan, J.; Brennan, D.M.; Bradley, N.; Gao, B.; Bruckdorfer, R.; Jacobs, M. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J., 1998, 300, 795-801.
[9]
Nourooz-Zadeh, J.; Tjaddini-Sarmadi, J.; Wolff, S.P. Measurement of plasma hydroperoxide concentrations by ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem., 1994, 220, 403-409.
[10]
Banerjee, M.; Kang, K.H.; Morrow, J.D.; Roberts, L.J.; Newman, J.H. Effects of a novel prostaglandin, 8-epi-PGF2 alpha in rabbit lung in situ. Am. J. Physiol., 1992, 263, H660.
[11]
Pratico, D.; Lawson, J.A.; FitzGerald, G.A. Cylooxygenase-dependent formation of the isoprostane, 8-Epi prostaglandin F-2α. J. Biol. Chem., 1995, 270, 9800.
[12]
Matata, B.M.; Galiñanes, M. Peroxynitrite is an essential component of cytokine production by monocytes by altering DNA-binding capacity of NF-kappa B. J. Biol. Chem., 2002, 277, 2330-2335.
[13]
Kyriakis, J.M. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr., 1999, 7, 217-231.
[14]
Kuwahara, F.; Kai, H.; Tokuda, K.; Kai, M.; Takeshita, A.; Egashira, K.; Imaizumi, T. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation, 2002, 106, 130-135.
[15]
Sivasubramanian, N.; Coker, M.L.; Kurrelmeyer, K.; DeMayo, F.; Spinale, F.G.; Mann, D.L. Left ventricular remodelling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation, 2001, 2001, 826-831.
[16]
Kapadia, S.; Oral, H.; Lee, J.; Nakano, M.; Taffet, G.E.; Mann, D.L. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ. Res., 1997, 81, 187-195.
[17]
Blackwell, T.S.; Christman, J.E. The role of nuclear factor-κB in cytokine gene regulation. Am. J. Respir. Cell. Mol., 1997, 17, 3-9.
[18]
Brand, K.; Eisele, T.; Kreusel, U.; Page, M.; Page, S.; Haas, M.; Gerling, A.; Kaltschmidt, C.; Neumann, F-J.; Mackman, N.; Patrick, A. Baeuerle, P.A.; Autar K. Walli, A.K.; Neumeier, D. Dyregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 1901-1909.
[19]
Ferari, R.; Bachetti, T.; Confortini, R.; Opasich, C.; Febo, O.; Corti, A.; Cassani, G.; Visioli, O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive failure. Circulation, 1995, 92, 1479-1486.
[20]
Tamura, N.; Ogawa, Y.; Chusho, H.; Nakamura, K.; Nakao, K.; Suda, M.; Kasahara, M.; Hashimoto, R.; Katsuura, G.; Mukoyama, M.; Itoh, H.; Saito, Y.; Tanaka, I.; Otani, H.; Katsuki, M. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. USA, 2000, 97, 4239-4244.
